deuteporfin

Small moleculeexperimental

Clinical trial activity

2 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2011 (NCT01481597)

Timeline

2010s

  1. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2017

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • deuteporfin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02955771Phase 2May 17, 2017Shanghai Zhangjiang Biotechnology Limited Company, Sun Yat-Sen University
NCT01481597Phase 1Nov 1, 2011Central South University, Shanghai Zhangjiang Biotechnology Limited Company
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Shanghai Zhangjiang Biotechnology Limited CompanyFor profit2222011
Central South UniversityAcademic/Hospital1012011
Sun Yat-Sen UniversityAcademic/Hospital1012017
3 organizations
Page 1 / 1